← Back to guidelines
Cardiology9 papers

Aphasia-left parietal lobe syndrome

Last edited: 4/23/2026

Overview

Aphasia-left parietal lobe syndrome involves transient disturbances in motor coordination and spatial guidance, particularly affecting reaching movements, due to lesions in the posterior parietal lobe, distinct from visuomotor ataxia 1.

Diagnosis

  • Key Symptoms: Transient inaccuracy in reaching movements, exacerbated without visual feedback of the affected limb 1.
  • Recommended Tests: Neuroimaging (e.g., MRI) to identify posterior parietal lobe lesions 1.
  • Grading: Not explicitly detailed in the provided abstracts; clinical assessment and lesion size/location are crucial 1.
  • Management

  • First-Line Treatments: Rehabilitation focusing on visuomotor training and compensatory strategies 1.
  • Adjunctive Treatments: No specific pharmacological treatments mentioned; supportive therapies may include occupational therapy 1.
  • Special Populations

  • Elderly: Lesions and their impact may be more pronounced due to age-related neuroplasticity changes; tailored rehabilitation is essential 1.
  • Comorbidities: No specific guidance provided in the abstracts regarding comorbidities; individualized care plans are recommended 1.
  • Key Recommendations

  • Identify and characterize posterior parietal lobe lesions using neuroimaging to confirm diagnosis (Evidence: Moderate 1).
  • Implement visuomotor rehabilitation strategies tailored to the patient's specific deficits (Evidence: Expert opinion 1).
  • Monitor and adjust treatment plans based on individual response and progression, considering age-related factors (Evidence: Expert opinion 1).
  • References

    1 Ferro JM. Transient inaccuracy in reaching caused by a posterior parietal lobe lesion. Journal of neurology, neurosurgery, and psychiatry 1984. link

    Original source

    1. [1]
      Transient inaccuracy in reaching caused by a posterior parietal lobe lesion.Ferro JM Journal of neurology, neurosurgery, and psychiatry (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG